---
figid: PMC11216359__iaa-2024-0185-0007-537837_F02
pmcid: PMC11216359
image_filename: iaa-2024-0185-0007-537837_F02.jpg
figure_link: /pmc/articles/PMC11216359/figure/F2/
number: Fig. 2
figure_title: ''
caption: 'T-96 treatment attenuated AHR in OVA-induced asthma. a Change of the airway
  resistance (Raw) in response to increasing concentrations of aerosolized methacholine
  in mice after last challenge. b Change of the lung compliance dynamic compliance
  (Cdyn) in response to increasing concentrations of aerosolized methacholine in mice
  after last challenge. Data were presented as mean ± SEM (n = 5–10 per group). **p
  < 0.01, ****p < 0.0001 versus control; ##p < 0.01, ###p < 0.001, ####p < 0.0001
  versus asthma.'
article_title: Demethylzeylasteral (T-96) Alleviates Allergic Asthma via Inhibiting
  MAPK/ERK and NF-κB Pathway.
citation: Jianan Huang, et al. Int Arch Allergy Immunol. 2024 Jul;185(7):631-640.
year: '2024'

doi: 10.1159/000537837
journal_title: International Archives of Allergy and Immunology
journal_nlm_ta: Int Arch Allergy Immunol
publisher_name: S. Karger AG

keywords:
- Demethylzeylasteral
- Allergic asthma
- MAPK
- NF-κB
- Cytokines

---
